Merrimack, Baxalta initiate phase I study of MM-151 for colorectal cancer May 24, 2016 CenterWatch Staff
FDA’s proposed Expanded Access Navigator points to progress, not panacea May 23, 2016 CenterWatch Staff
Vince & Associates’ new research center reflects recent QT regulatory changes May 23, 2016 CenterWatch Staff